IntrinsicIntrinsic
← All summaries

Marvell Technology, Inc.

MRVL
Financials & Chart →

Business Summary

Marvell Technology, Inc. is a leading supplier of data infrastructure semiconductor solutions, spanning the data center core to network edge, operating as a fabless supplier of high-performance semiconductor products with core strengths in developing and scaling complex System-on-a-Chip architectures that integrate analog, mixed-signal and digital signal processing functionality. The company serves two end markets: data center and communications and other, with its solutions empowering the data economy through compute, networking, security, interconnects, and storage technologies. The filing does not disclose an overall market size or growth rate for the semiconductor industry, but it notes that the data center end market generated $6,100.3 million in revenue in fiscal 2026, representing 74% of total net revenue, compared to $4,164.2 million and 72% in fiscal 2025, and $2,216.7 million and 40% in fiscal 2024, indicating a structural shift toward AI-related demand as a key force shaping competition.

The filing names numerous direct competitors including Advanced Micro Devices, Inc., Alchip Technologies, Astera Labs, Inc., Ayar Labs, Inc., Broadcom Inc., Cisco Systems, Inc., Credo Technology Group Holding Ltd, Intel Corporation, Global Unichip Corporation, Lightmatter, Inc., MACOM Technology Solutions Holdings, Inc., MediaTek Inc., Microchip Technology Inc., Montage Technology, Nvidia Corporation, NXP Semiconductors N.V., Phison Electronics Corporation, Qualcomm Incorporated, Rambus, Inc., Ranovus Inc., Realtek Semiconductor Corporation, Semtech Corporation, Silicon Motion Technology Corporation, and Socionext Inc. The filing states that competition has intensified due to increasing demand for higher levels of performance, integration, and smaller process geometries, and that some customers have chosen to develop certain semiconductor products internally, a trend that may continue. The company believes its ability to compete depends on factors including product performance, features, quality and price; development execution and timing of new product introductions; emergence and adoption of new industry standards; market demand trends; competitive tactics; ability to obtain adequate foundry capacity; and the number and nature of competitors in a given market.

Marvell generates revenue primarily through the sale of high-performance semiconductor solutions, including custom Application Specific Integrated Circuits (ASICs), interconnects, ethernet solutions, fibre channel adapters, processors, and storage controllers, with the majority of revenue derived from product sales recognized at a point in time upon transfer of control to the customer. The company sells to original equipment manufacturers (OEMs), original design manufacturers, and distributors, and it offers both standard product solutions sold to multiple customers and optimized solutions customized to specific customer requirements, with demand for optimized solutions increasing as customers seek greater customization. Revenue from direct customers was $4,630.4 million in fiscal 2026, representing 57% of total net revenue, while revenue from distributors was $3,564.2 million , representing 43% of total net revenue.

The data center end market generated $6,100.3 million in net revenue in fiscal 2026, representing 74% of total net revenue, compared to $4,164.2 million and 72% in fiscal 2025, and $2,216.7 million and 40% in fiscal 2024. This end market serves cloud and on-premise AI systems, ethernet switching, network-attached storage, AI servers, general-purpose servers, storage area networks, storage systems, and data center interconnect applications. The company's product offerings for this market include custom ASICs built on a proven platform leveraging ultra-high-speed SerDes, ARM compute, security, storage, silicon photonics and advanced packaging; a complete portfolio of high-speed interconnect solutions including PAM DSPs, coherent and coherent-lite DSPs, laser drivers, TIAs, silicon photonics, CPO, LPO chipsets, DCI solutions, AEC DSPs, and PCIe retimers; Ethernet solutions spanning controllers, network adapters, physical transceivers and switches including Prestera and Teralynx switches; scale-up switches including UALink and ESUN switch fabrics; PCIe and CXL switches from the XConn acquisition; Fibre Channel products including host bus adapters and controllers; processors including OCTEON DPUs, OCTEON Fusion wireless baseband infrastructure processors, NITROX security processors, LiquidSecurity transaction security solutions, and LiquidIO server adapters; and storage controllers including Bravera HDD and SSD controllers.

The communications and other end market generated $2,094.3 million in net revenue in fiscal 2026, representing 26% of total net revenue, compared to $1,603.1 million and 28% in fiscal 2025, and $3,291.0 million and 60% in fiscal 2024. Beginning in the fourth quarter of fiscal 2026, the company consolidated revenue previously reported separately as enterprise networking, carrier infrastructure, consumer, and automotive/industrial end markets into this new communications and other end market. This end market serves enterprise networking applications (campus and SME routers, ethernet switches, wireless access points, network appliances, workstations), carrier infrastructure (broadband access systems, ethernet switches, optical transport systems, routers, wireless RAN systems), consumer applications (broadband gateways and routers, gaming consoles, home data storage, home WAPs, PCs, printers, set-top boxes), and automotive/industrial applications (ADAS, autonomous vehicles, in-vehicle networking, industrial ethernet switches, U.S. military and government solutions, video surveillance), though the automotive ethernet business was divested on August 14, 2025.

On August 14, 2025, the company completed the sale of its automotive ethernet business to Infineon Technologies AG for $2.5 billion in cash, recording a pre-tax gain on sale of $1.8 billion in the third quarter of fiscal 2026. Subsequent to fiscal year end, on February 2, 2026, the company completed the acquisition of Celestial AI, Inc., paying approximately $1.3 billion in cash (or $1.0 billion , net of cash acquired of approximately $300.0 million ) and issuing approximately 24.5 million shares of common stock, with potential additional cash and share consideration through fiscal 2029 contingent on revenue milestones. Also subsequent to fiscal year end, on February 10, 2026, the company completed the acquisition of XConn Technologies Holdings, Ltd., paying approximately $280.0 million in cash and issuing approximately 2.1 million shares of common stock. During fiscal 2026, the company repurchased 26.6 million shares of common stock for $2.0 billion , paid $205.1 million in cash dividends, and had $5.5 billion remaining available for future stock repurchases as of January 31, 2026. The company also entered into a $5.0 billion addition to its stock repurchase program authorized on September 24, 2025, and executed an accelerated share repurchase agreement with an upfront payment of $1.0 billion that resulted in cumulative repurchases of 11.7 million shares at an average price of $85.21 per share.

Net revenue in fiscal 2026 was $8,194.6 million , 42.1% higher than net revenue of $5,767.3 million in fiscal 2025, driven by a 46% increase in data center end market sales from AI-related demand and a 31% increase in communications and other end market sales from revenue recovery, partially offset by the divestiture of the automotive ethernet business. Gross profit was $4,180.7 million with a gross margin of 51.0% in fiscal 2026, compared to $2,382.2 million and 41.3% in fiscal 2025, an improvement of 9.7 percentage points primarily due to impairment charges in the prior year and better cost absorption. Net income was $2,670.1 million in fiscal 2026, compared to a net loss of $885.0 million in fiscal 2025, with diluted EPS of $3.07 versus a loss per share of $1.02 in the prior year. Cash and cash equivalents were $2,638.8 million at January 31, 2026, compared to $948.3 million at February 1, 2025, an increase of $1,690.5 million .

Business Outlook

The primary growth vector discussed is the data center end market, particularly AI-related demand. The filing states that strong revenue growth from the data center market was driven by AI-related demand for custom products and the electro-optics portfolio, and that the company is developing advanced products at 2nm, 1.4nm, and smaller geometries featuring gate-all-around transistor design and innovations in back side power delivery. The company is also developing Ultra Accelerator Link (UALink) switches and Ethernet for Scale-Up Networking (ESUN) switches for the emerging scale-out AI market, and the acquisitions of Celestial AI (Photonic Fabric technology for next-generation scale-up interconnect) and XConn (advanced PCIe and CXL switching silicon) are expected to accelerate the connectivity strategy for next-generation AI and cloud data centers. The filing notes that the company has successfully executed multiple 5nm designs, is progressing through 3nm designs, and is developing an advanced 2nm generation platform.

A second growth vector is the recovery in the communications and other end market. The filing states that following a period of inventory correction, the company has continued to see revenue recovery in its communication and other end market, growing significantly compared to fiscal 2025, with a 31% increase in sales. The company also notes that it is developing custom ASICs for next-generation artificial intelligence, data center, compute, networking, carrier, storage, aerospace and defense applications, built on a proven ASIC platform that leverages a broad suite of differentiated Marvell intellectual property including ultra-high-speed SerDes, ARM compute, security, storage, silicon photonics and advanced packaging.

The filing discusses margin trajectory primarily through the lens of gross margin improvement. Gross margin for fiscal 2026 increased by 9.7 percentage points compared to fiscal 2025, reaching 51.0% , driven by better cost absorption from higher revenues and the absence of prior-year impairment charges. The filing notes that cost of goods sold as a percentage of net revenue decreased primarily due to impairment charges of $357.9 million for acquired intangible assets, inventories, property and equipment, and other non-current assets associated with restructuring actions during fiscal 2025, as well as better cost absorption partially offset by a shift in product mix. The company expects that average unit selling prices will continue to be subject to significant pricing pressures and that it will need to continue to introduce innovative new products and reduce design and manufacturing costs to offset expected declines.

The filing describes the company's operational posture as reliant on third-party manufacturing partners, with most products fabricated by foundries located in Taiwan and assembly, testing and packaging facilities primarily in China, Malaysia, Singapore, Taiwan and Canada. The company typically places firm orders with suppliers up to 26 weeks prior to anticipated delivery and may make further supply commitments up to 52 weeks to secure capacity. To secure capacity over the long term, the company has entered into capacity reservation arrangements with certain foundries and partners, with purchase level commitments of at least $458.2 million of wafers, substrates, and other manufacturing products for fiscal 2027 through fiscal 2033 under capacity reservation agreements. The company employed 7,480 people as of January 31, 2026, with 49% based in the Americas, 42% in APAC (including India), and 9% in EMEA.

Research and development expense was $2,075.2 million in fiscal 2026, representing 25.3% of net revenue, compared to $1,950.4 million and 33.9% in fiscal 2025, an increase of $124.8 million primarily due to higher overall spending to support R&D initiatives including advanced IP development and customer design win activity. Capital expenditures were $354.1 million in fiscal 2026, compared to $284.6 million in fiscal 2025. The company had $5.5 billion remaining available for future stock repurchases as of January 31, 2026, and paid $205.1 million in cash dividends during fiscal 2026 at $0.24 per share. The company's Board of Directors authorized a $5.0 billion addition to the stock repurchase program on September 24, 2025. The filing does not disclose a specific dividend policy or future dividend rate.

The filing identifies several structural headwinds and constraints. The company faces risks related to U.S. government export restrictions on certain Chinese customers, which have dampened demand and may continue to impact revenue, with the filing noting that a small portion of products shipped to China remain there and that some customers in China may amass large inventories or replace products with alternatives. The company also faces risks from tariffs and trade restrictions, including a 25% tariff and other requirements issued by BIS in January 2026, and potential revenue-sharing arrangements that could erode gross margins. Additionally, the filing notes that the current level of capital expenditure on AI infrastructure may not be sustainable over the long term and that a significant reduction in AI-related spending would likely harm financial results.

The filing identifies geographic and macroeconomic constraints, noting that sales shipped to customers with operations in Asia represented approximately 77% of net revenue in fiscal 2026 and 75% in fiscal 2025, and that most products are manufactured by third-party foundries located in Taiwan, exposing the company to risks from regional events including droughts, earthquakes, tsunamis, typhoons, power outages, and geopolitical tensions. The company also faces risks from the armed conflict in Israel and the Middle East, where it has employees, and from potential disruptions to business in Taiwan due to political or military events. The filing further notes that the company is subject to risks from inflation, rising interest rates, and potential recessions that could cause customers to cancel orders or delay purchasing decisions.

Risk Factors

The company's revenue is highly concentrated, with two customers (one distributor and one direct customer) each representing 10% or more of total net revenue in fiscal 2026, and the ten largest customers representing 82% of total net revenue, exposing the company to significant risk if any key customer reduces purchases or experiences financial difficulties. The company faces material risk from U.S. government export restrictions on sales to China, which have dampened demand and may continue to impact revenue, with the filing noting that a 25% tariff and other requirements were issued by BIS in January 2026, and that potential revenue-sharing arrangements could erode gross margins. The company is exposed to supply chain concentration risk as most products are manufactured by third-party foundries located in Taiwan, and the company had $4,499.9 million in total debt outstanding as of January 31, 2026, with $499.8 million due within twelve months, which could limit financial flexibility. The company had $11,062.2 million of goodwill and $1,754.7 million of acquired intangible assets on the balance sheet as of January 31, 2026, exposing it to potential impairment charges if business performance declines, as evidenced by the $711.8 million in restructuring-related impairment charges recognized in fiscal 2025.

Management Priorities

Management's message emphasizes the company's transformation toward a data center-centric business, with net revenue in fiscal 2026 reaching $8,194.6 million , 42% higher than the prior year, driven by AI-related demand for custom products and the electro-optics portfolio. The filing highlights the strategic divestiture of the automotive ethernet business for $2.5 billion in cash and the subsequent acquisitions of Celestial AI and XConn Technologies to accelerate the connectivity strategy for next-generation AI and cloud data centers. Management's key strategic priorities include continuing to invest in research and development, with R&D expense of $2,075.2 million in fiscal 2026, advancing product development at 2nm, 1.4nm, and smaller geometries, and returning capital to stockholders through $2.0 billion in share repurchases and $205.1 million in dividends during fiscal 2026.

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  2. [2] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  3. [3] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  4. [4] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  5. [5] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  6. [6] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  7. [7] Item 8, Note 3 — Revenue
  8. [8] Item 8, Note 3 — Revenue
  9. [9] Item 8, Note 3 — Revenue
  10. [10] Item 8, Note 3 — Revenue
  11. [11] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  12. [12] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  13. [13] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  14. [14] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  15. [15] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  16. [16] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  17. [17] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  18. [18] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  19. [19] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  20. [20] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  21. [21] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  22. [22] Item 7, MD&A — Results of Operations; Item 8, Note 3 — Revenue
  23. [23] Item 1, Business — Recent Developments; Item 7, MD&A — Overview
  24. [24] Item 1, Business — Recent Developments; Item 7, MD&A — Overview
  25. [25] Item 1, Business — Recent Developments; Item 7, MD&A — Overview
  26. [26] Item 1, Business — Recent Developments; Item 7, MD&A — Overview
  27. [27] Item 1, Business — Recent Developments; Item 7, MD&A — Overview
  28. [28] Item 1, Business — Recent Developments; Item 7, MD&A — Overview
  29. [29] Item 1, Business — Recent Developments; Item 7, MD&A — Overview
  30. [30] Item 1, Business — Recent Developments; Item 7, MD&A — Overview
  31. [31] Item 5, Issuer Purchases of Equity Securities; Item 8, Note 10 — Stockholders' Equity
  32. [32] Item 5, Issuer Purchases of Equity Securities; Item 8, Note 10 — Stockholders' Equity
  33. [33] Item 5, Dividends; Item 8, Note 10 — Stockholders' Equity
  34. [34] Item 5, Issuer Purchases of Equity Securities; Item 8, Note 10 — Stockholders' Equity
  35. [35] Item 5, Issuer Purchases of Equity Securities; Item 8, Note 10 — Stockholders' Equity
  36. [36] Item 5, Issuer Purchases of Equity Securities; Item 8, Note 10 — Stockholders' Equity
  37. [37] Item 5, Issuer Purchases of Equity Securities; Item 8, Note 10 — Stockholders' Equity
  38. [38] Item 5, Issuer Purchases of Equity Securities; Item 8, Note 10 — Stockholders' Equity
  39. [39] Item 7, MD&A — Overview; Item 8, Consolidated Statements of Operations
  40. [40] Item 7, MD&A — Net Revenue
  41. [41] Item 7, MD&A — Overview; Item 8, Consolidated Statements of Operations
  42. [42] Item 7, MD&A — Net Revenue
  43. [43] Item 7, MD&A — Net Revenue
  44. [44] Item 8, Consolidated Statements of Operations
  45. [45] Item 7, MD&A — Cost of Goods Sold and Gross Profit
  46. [46] Item 8, Consolidated Statements of Operations
  47. [47] Item 7, MD&A — Cost of Goods Sold and Gross Profit
  48. [48] Item 7, MD&A — Cost of Goods Sold and Gross Profit
  49. [49] Item 8, Consolidated Statements of Operations
  50. [50] Item 8, Consolidated Statements of Operations
  51. [51] Item 8, Consolidated Statements of Operations
  52. [52] Item 8, Consolidated Statements of Operations
  53. [53] Item 8, Consolidated Balance Sheets
  54. [54] Item 8, Consolidated Balance Sheets
  55. [55] Item 8, Consolidated Statements of Cash Flows
  56. [56] Item 7, MD&A — Net Revenue
  57. [57] Item 7, MD&A — Cost of Goods Sold and Gross Profit
  58. [58] Item 7, MD&A — Cost of Goods Sold and Gross Profit
  59. [59] Item 7, MD&A — Cost of Goods Sold and Gross Profit; Item 8, Note 4 — Restructuring
  60. [60] Item 1, Business — Inventory and Working Capital
  61. [61] Item 1, Business — Inventory and Working Capital
  62. [62] Item 8, Note 8 — Commitments and Contingencies
  63. [63] Item 1, Business — Human Capital
  64. [64] Item 1, Business — Human Capital
  65. [65] Item 1, Business — Human Capital
  66. [66] Item 1, Business — Human Capital
  67. [67] Item 7, MD&A — Research and Development; Item 8, Consolidated Statements of Operations
  68. [68] Item 7, MD&A — Research and Development
  69. [69] Item 7, MD&A — Research and Development; Item 8, Consolidated Statements of Operations
  70. [70] Item 7, MD&A — Research and Development
  71. [71] Item 7, MD&A — Research and Development
  72. [72] Item 8, Consolidated Statements of Cash Flows
  73. [73] Item 8, Consolidated Statements of Cash Flows
  74. [74] Item 5, Issuer Purchases of Equity Securities; Item 8, Note 10 — Stockholders' Equity
  75. [75] Item 5, Dividends; Item 8, Note 10 — Stockholders' Equity
  76. [76] Item 5, Dividends; Item 8, Note 10 — Stockholders' Equity
  77. [77] Item 5, Issuer Purchases of Equity Securities; Item 8, Note 10 — Stockholders' Equity
  78. [78] Item 1A, Risk Factors — Adverse changes in the political, regulatory and economic policies of governments in connection with trade with China
  79. [79] Item 7, MD&A — Sales and Customer Composition
  80. [80] Item 7, MD&A — Sales and Customer Composition
  81. [81] Item 1A, Risk Factors — Our sales are concentrated in a few large customers
  82. [82] Item 1A, Risk Factors — Adverse changes in the political, regulatory and economic policies of governments in connection with trade with China
  83. [83] Item 8, Note 7 — Debt
  84. [84] Item 8, Note 7 — Debt
  85. [85] Item 8, Consolidated Balance Sheets; Item 8, Note 5 — Goodwill and Acquired Intangible Assets
  86. [86] Item 8, Consolidated Balance Sheets; Item 8, Note 5 — Goodwill and Acquired Intangible Assets
  87. [87] Item 8, Note 4 — Restructuring
  88. [88] Item 7, MD&A — Overview; Item 8, Consolidated Statements of Operations
  89. [89] Item 7, MD&A — Overview
  90. [90] Item 1, Business — Recent Developments; Item 7, MD&A — Overview
  91. [91] Item 7, MD&A — Research and Development; Item 8, Consolidated Statements of Operations
  92. [92] Item 5, Issuer Purchases of Equity Securities; Item 8, Note 10 — Stockholders' Equity
  93. [93] Item 5, Dividends; Item 8, Note 10 — Stockholders' Equity
  94. [94] Item 8, Consolidated Statements of Operations
  95. [95] Item 8, Consolidated Statements of Operations
  96. [96] Item 8, Consolidated Statements of Operations
  97. [97] Item 8, Consolidated Statements of Operations
  98. [98] Item 8, Consolidated Statements of Operations
  99. [99] Item 8, Consolidated Statements of Operations
  100. [100] Item 8, Consolidated Statements of Operations
  101. [101] Item 8, Consolidated Statements of Operations
  102. [102] Item 8, Consolidated Statements of Operations
  103. [103] Item 8, Consolidated Statements of Operations
  104. [104] Item 7, MD&A — Cost of Goods Sold and Gross Profit
  105. [105] Item 8, Consolidated Statements of Operations
  106. [106] Item 7, MD&A — Cost of Goods Sold and Gross Profit
  107. [107] Item 8, Consolidated Statements of Operations
  108. [108] Item 8, Consolidated Statements of Operations
  109. [109] Item 8, Consolidated Statements of Cash Flows
  110. [110] Item 8, Consolidated Statements of Cash Flows
  111. [111] Derived from Item 8, Consolidated Statements of Cash Flows
  112. [112] Item 8, Consolidated Statements of Cash Flows
  113. [113] Item 8, Consolidated Statements of Cash Flows
  114. [114] Item 8, Consolidated Balance Sheets
  115. [115] Item 8, Consolidated Balance Sheets
  116. [116] Item 8, Note 7 — Debt
  117. [117] Item 8, Note 7 — Debt
  118. [118] Item 8, Note 3 — Revenue
  119. [119] Item 8, Note 3 — Revenue
  120. [120] Item 1, Business — Recent Developments; Item 7, MD&A — Overview
  121. [121] Item 8, Note 4 — Restructuring
  122. [122] Item 8, Note 4 — Restructuring
  123. [123] Item 8, Note 4 — Restructuring
  124. [124] Item 8, Note 4 — Restructuring

Analysis on 6/8/2026